Altre lingue Karolinska Development AB

Azioni

KDEV

SE0002190926

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:17:16 03/05/2024			Variaz. 5gg	Var. 1 gen.
1,58 ^SEK	0,00%		+0,64%	-6,95%

26/04	Karolinska Development AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
16/04	Karolinska Development AB (Publ) annuncia che Bjorn Cochlovius ha rifiutato la rielezione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Interim Report - January-March 2024	26/04
Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Notice of Annual General Meeting in Karolinska Development AB (publ)	16/04
Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election	16/04
Karolinska Development : portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC	22/03
Karolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBC	22/03
Karolinska Development Annual Report 2023 published	22/03
Karolinska Development Annual Report 2023 published	22/03
Karolinska Development : portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million	14/03
Karolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 million	14/03
Karolinska Development : portfolio company Biosergen publishes prospectus due to rights issue of units	14/03
Karolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of units	14/03
Karolinska Development : portfolio company Umecrine Cognition presents preclinical Parkinson's data on golexanolone at AD/PD	06/03
Karolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PD	06/03
Year-end Report - January-December 2023	16/02
Karolinska Development AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Karolinska Development Portfolio Company AnaCardio Completes SEK150 Million Funding Round	17/01
Karolinska Development’s portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round	17/01
AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB	17/01
Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product	09/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Karolinska Development AB

Azioni

KDEV

SE0002190926

Altre lingue

Filtri